Tom Gayner’s Teva Pharmaceuticals TEVA Stock Holding History

Tom Gayner’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-444,000	Closed	-$23.9M	–	110
2014 Q3	$23.9M	Sell	444,000 -250,000	-36%	-$13.2M	0.67%	43
2014 Q2	$36.4M	Hold	694,000	–	–	1.04%	29
2014 Q1	$36.7M	Sell	694,000 -5,900	-0.8%	-$273K	1.13%	27
2013 Q4	$28.1M	Sell	699,900 -100	-0%	-$3.94K	0.89%	31
2013 Q3	$26.4M	Buy	700,000 +1,000	+0.1%	+$39K	0.91%	30
2013 Q2	$27.4M	Buy	+699,000	New	+$27.2M	0.98%	29

Other funds holding TEVA

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 30.2% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Tom Gayner's TEVA Position: Q4 2014 in Review

Tom Gayner sold out of Teva Pharmaceuticals (TEVA) in Q4 2014, closing a stake of 444,000 shares — an estimated $23.9M sold.

Tom Gayner first reported a position in TEVA in Q2 2013 and held it in 6 quarters. The position peaked at $36.7M in Q1 2014. 822 funds tracked by Wall St. Rank hold TEVA as of Q4 2014.

Tom Gayner reported no remaining Teva Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
Tom Gayner sold 444,000 Teva Pharmaceuticals shares in Q4 2014, an estimated $23.9M.
Tom Gayner first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 6 quarters.
Tom Gayner's Teva Pharmaceuticals position peaked at $36.7M in Q1 2014.
822 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2014.

Based on Markel Group's 13F filing for Q4 2014, filed 9 Feb 2015.